These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34626722)

  • 1. High ORAI3 expression correlates with good prognosis in human muscle-invasive bladder cancer.
    Yan J; Yu W; Lu C; Liu C; Wang G; Jiang L; Jiang Z; Qin Z
    Gene; 2022 Jan; 808():145994. PubMed ID: 34626722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of prognostic biomarkers associated with stromal cell infiltration in muscle-invasive bladder cancer by bioinformatics analyses.
    Li P; Cao J; Li J; Yao Z; Han D; Ying L; Wang Z; Tian J
    Cancer Med; 2020 Oct; 9(19):7253-7267. PubMed ID: 32786144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of an Immune-Associated Gene-Based Signature in Muscle-Invasive Bladder Cancer.
    Shen C; Xu T; Sun Y; Wang L; Liang Z; Niu H; Jiao W; Wang Y
    Dis Markers; 2020; 2020():8866730. PubMed ID: 33456631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An immune relevant signature for predicting prognoses and immunotherapeutic responses in patients with muscle-invasive bladder cancer (MIBC).
    Jiang W; Zhu D; Wang C; Zhu Y
    Cancer Med; 2020 Apr; 9(8):2774-2790. PubMed ID: 32096345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High S100A7 expression is associated with early muscle invasion and poor survival in bladder carcinoma.
    Dong Y; Zhu GY; Hao L; Liang Q; Zhou JH; Shi ZD; Yu H; Ma WM; Fan T; Zhang WD; Zang GH; Han CH
    Ann Diagn Pathol; 2022 Feb; 56():151847. PubMed ID: 34742033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic screening of protein-coding gene expression identified HMMR as a potential independent indicator of unfavorable survival in patients with papillary muscle-invasive bladder cancer.
    Yang D; Ma Y; Zhao P; Ma J; He C
    Biomed Pharmacother; 2019 Dec; 120():109433. PubMed ID: 31568988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibronectin-1: A Predictive Immunotherapy Response Biomarker for Muscle‑Invasive Bladder Cancer.
    Zhang X; Liu H; Zhang J; Wang Z; Yang S; Liu D; Liu J; Li Y; Fu X; Zhang X
    Arch Esp Urol; 2023 Feb; 76(1):70-83. PubMed ID: 36914422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Immune and Stromal Infiltration on Outcomes Following Bladder-Sparing Trimodality Therapy for Muscle-Invasive Bladder Cancer.
    Efstathiou JA; Mouw KW; Gibb EA; Liu Y; Wu CL; Drumm MR; da Costa JB; du Plessis M; Wang NQ; Davicioni E; Feng FY; Seiler R; Black PC; Shipley WU; Miyamoto DT
    Eur Urol; 2019 Jul; 76(1):59-68. PubMed ID: 30712971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of long non-coding RNA TUG1 predicts poor prognosis and promotes cancer cell proliferation and migration in high-grade muscle-invasive bladder cancer.
    Iliev R; Kleinova R; Juracek J; Dolezel J; Ozanova Z; Fedorko M; Pacik D; Svoboda M; Stanik M; Slaby O
    Tumour Biol; 2016 Oct; 37(10):13385-13390. PubMed ID: 27460088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor‑infiltrating M2 macrophages driven by specific genomic alterations are associated with prognosis in bladder cancer.
    Xue Y; Tong L; LiuAnwei Liu F; Liu A; Zeng S; Xiong Q; Yang Z; He X; Sun Y; Xu C
    Oncol Rep; 2019 Aug; 42(2):581-594. PubMed ID: 31233191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Robust Hypoxia Risk Score Predicts the Clinical Outcomes and Tumor Microenvironment Immune Characters in Bladder Cancer.
    Liu Z; Tang Q; Qi T; Othmane B; Yang Z; Chen J; Hu J; Zu X
    Front Immunol; 2021; 12():725223. PubMed ID: 34484235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Subtypes of Urothelial Bladder Cancer: Results from a Meta-cohort Analysis of 2411 Tumors.
    Tan TZ; Rouanne M; Tan KT; Huang RY; Thiery JP
    Eur Urol; 2019 Mar; 75(3):423-432. PubMed ID: 30213523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of long non-coding RNAs that stimulate cell survival in bladder cancer.
    Dudek AM; Boer SJ; Boon N; Witjes JA; Kiemeney LALM; Verhaegh GW
    Oncotarget; 2017 May; 8(21):34442-34452. PubMed ID: 28415801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Siglec15 shapes a non-inflamed tumor microenvironment and predicts the molecular subtype in bladder cancer.
    Hu J; Yu A; Othmane B; Qiu D; Li H; Li C; Liu P; Ren W; Chen M; Gong G; Guo X; Zhang H; Chen J; Zu X
    Theranostics; 2021; 11(7):3089-3108. PubMed ID: 33537076
    [No Abstract]   [Full Text] [Related]  

  • 15. High expression of MMP14 is associated with progression and poor short-term prognosis in muscle-invasive bladder cancer.
    Wang JF; Gong YQ; He YH; Ying WW; Li XS; Zhou XF; Zhou LQ
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6605-6615. PubMed ID: 32633349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular matrix-related genes play an important role in the progression of NMIBC to MIBC: a bioinformatics analysis study.
    Zhang H; Shan G; Song J; Tian Y; An LY; Ban Y; Luo GH
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32391563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic expression changes between non-muscle-invasive bladder cancer and muscle-invasive bladder cancer.
    Zhao YG; Shi BY; Qian YY; Bai HW; Xiao L; He XY
    Tumori; 2014; 100(6):e273-81. PubMed ID: 25688510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA expression profiles in muscle-invasive bladder cancer: identification of a four-microRNA signature associated with patient survival.
    Xu Z; Yu YQ; Ge YZ; Zhu JG; Zhu M; Zhao YC; Xu LW; Yang XB; Geng LG; Dou QL; Jia RP
    Tumour Biol; 2015 Sep; 36(10):8159-66. PubMed ID: 25990459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of prognostic signature based on immune-related genes in muscle-invasive bladder cancer: bioinformatics analysis of TCGA database.
    Jin K; Qiu S; Jin D; Zhou X; Zheng X; Li J; Liao X; Yang L; Wei Q
    Aging (Albany NY); 2021 Jan; 13(2):1859-1871. PubMed ID: 33465047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Power of a Tumor Differentiation Gene Signature for Bladder Urothelial Carcinomas.
    Mo Q; Nikolos F; Chen F; Tramel Z; Lee YC; Hayashi K; Xiao J; Shen J; Chan KS
    J Natl Cancer Inst; 2018 May; 110(5):448-459. PubMed ID: 29342309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.